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The rise of molecular genetics is having a pervasive inﬂuence in a wide variety of ﬁelds,
including research into neurodevelopmental disorders like dyslexia, speech and language
impairments, and autism. There are many studies underway which are attempting to deter-
mine the roles of genetic factors in the aetiology of these disorders. Beyond the obvious impli-
cations for diagnosis, treatment and understanding, success in these eﬀorts promises to shed
light on the links between genes and aspects of cognition and behaviour. However, the decep-
tive simplicity of ﬁnding correlations between genetic and phenotypic variation has led to a
common misconception that there exist straightforward linear relationships between speciﬁc
genes and particular behavioural and/or cognitive outputs. The problem is exacerbated by
the adoption of an abstract view of the nature of the gene, without consideration of molecular,
developmental or ontogenetic frameworks. To illustrate the limitations of this perspective, I
select two cases from recent research into the genetic underpinnings of neurodevelopmental
disorders. First, I discuss the proposal that dyslexia can be dissected into distinct components
speciﬁed by diﬀerent genes. Second, I review the story of the FOXP2 gene and its role in
human speech and language. In both cases, adoption of an abstract concept of the gene can
lead to erroneous conclusions, which are incompatible with current knowledge of molecular
and developmental systems. Genes do not specify behaviours or cognitive processes; they
make regulatory factors, signalling molecules, receptors, enzymes, and so on, that interact
in highly complex networks, modulated by environmental inﬂuences, in order to build and
maintain the brain. I propose that it is necessary for us to fully embrace the complexity of bio-
logical systems, if we are ever to untangle the webs that link genes to cognition.
 2006 Elsevier B.V. All rights reserved.0010-0277/$ - see front matter  2006 Elsevier B.V. All rights reserved.
doi:10.1016/j.cognition.2006.04.004
* Tel.: +44 1865 287647; fax: +44 1865 287650.
E-mail address: simon.ﬁsher@well.ox.ac.uk
S.E. Fisher / Cognition 101 (2006) 270–297 271Keywords: Genetics; Linkage analysis; Association analysis; Developmental dyslexia; Speech and langu-
age disorders; Autism; FOXP21. Introduction
In recent years we have witnessed some extraordinary advances in the ﬁeld of
molecular genetics (Collins, Green, Guttmacher, & Guyer, 2003). Since this research
area has the potential to impact on a diverse range of other disciplines within the nat-
ural sciences, such advances are having a pervasive inﬂuence on multiple ﬁelds of
biology. Human cognition is no exception; the past decade has seen a dramatic
increase in the number and scale of research programmes exploiting molecular
approaches for studying the human brain. There are now many laboratories world-
wide investigating the role of genetic factors in developmental learning disorders
(Fisher & DeFries, 2002; Fisher, Lai, & Monaco, 2003; Folstein & Rosen-Sheidley,
2001; Grigorenko, 2001) using the same molecular techniques that are being applied
to common human traits such as heart disease, hypertension, diabetes, asthma,
arthritis and so on (Botstein & Risch, 2003). Biologists are now in possession of
an exciting and powerful new toolkit for tackling their favourite research questions.
However, as is often the case, there is a catch. Although the emerging molecular
methods are deceptively easy to wield, the answers they present are far from straight-
forward. Making sense of them requires a novel mindset, one which is rooted in com-
plexity and unfamiliar to many. In the present article I begin by outlining the basic
concepts that underlie molecular genetic analyses of developmental disorders. I then
go on to argue that the common misconception of the gene as an abstract entity, able
to elusively control aspects of cognition, may impede attempts to connect genes with
cognition. Finally, I illustrate the key issues by considering a selection of pertinent
examples from recent studies of developmental dyslexia and speech and language
disorders. This is not intended as a general review of the ﬁeld; I speciﬁcally focus
on cases that best demonstrate the pitfalls of adopting an abstract view of the gene,
and that highlight the importance of integrating data from multiple levels of analy-
ses. I propose that we need to fully embrace the inherent molecular complexity of
developmental systems, if we want to further our understanding of genetic inﬂuences
on human cognition.2. Back to basics
As I illustrate elsewhere in this article, it is quite possible to carry out genetic anal-
yses with only an abstract perception of the nature of a gene. The relevant methods
are easily transposable to virtually any trait of interest (assuming that such a trait has
at least some heritable basis). However, a proper appreciation of the signiﬁcance of
genetic ﬁndings must depend on a solid foundation in basic molecular concepts, and
it is worth brieﬂy revisiting these before proceeding further. Given the blaze of
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aware that (i) genetic information is encoded by the sequence of nucleotides in a
molecule known as DNA, (ii) the genome represents the entire DNA sequence of
a particular organism; the full set of ‘‘instructions’’ for building and maintaining that
organism, (iii) almost every cell of a multi-cellular organism has its own copy of the
genome to refer to, and (iv) DNA molecules are tightly packaged (with proteins and
other molecules) into bodies known as chromosomes. Many people will also know
that the human genome, recently decoded, contains over 3 billion nucleotide letters.
But there are common gaps in understanding. For example, how does the concept of
‘‘the gene’’ ﬁt into this framework of DNA, chromosomes and genomes? How can
the linear code contained in a string of molecular letters specify the construction
and functions of a three-dimensional organism (in fact four-dimensional, since we
need to take into account temporal aspects)? If the whole human genome has indeed
been decoded and all the human genes have been found, then why are scientists still
‘‘mapping’’ the genes?
There are also a number of frequent misunderstandings of genetics, which persist
from a time when we did not have a molecular perspective, such as the idea that there
might literally be a ‘‘gene for dyslexia’’. This kind of term is a potentially misleading
piece of geneticists’ jargon, originating from the early days of the ﬁeld, in which a
gene is described purely in terms of the overall dysfunction associated with its loss
or mutation. Our ability to characterise genes has since moved on dramatically,
but the ‘‘gene for X’’ phraseology continues to be very extensively used both in
the literature and the media, mainly due to its eﬀectiveness in communicating the
importance of genetic inﬂuences. A wider but related issue is whether genes may exist
whose job it is to directly specify particular cognitive abilities (e.g. a ‘‘gene for gram-
mar’’, or a ‘‘gene for phoneme awareness’’). I will return to these points at the end of
this article, since they are central to common misconceptions regarding the role of
genes in cognition.
So, what is a gene? Answering this question is far from trivial, but a useful oper-
ational deﬁnition might be ‘‘a stretch of DNA whose linear sequence of nucleotides
encodes the linear sequence of amino acids in a speciﬁc protein’’. The amino acid
sequence of a protein determines the way that it folds, and hence its three-dimension-
al structure. The function of the resulting protein is tightly dependent on this three-
dimensional structure. As a consequence of variability in the combinations of amino
acids that can be strung together into polypeptides, genes are able to encode proteins
with a vast range of diﬀering functions. These include enzymes for catalyzing bio-
chemical reactions, proteins that are integral to the structure or motility of a cell,
molecules that are sent out as signals to other cells, receptors that receive those sig-
nals, channels that allow ions to pass in and/or out of a cell and many more, together
forming components of the ‘‘molecular machines of life’’ (Hood & Galas, 2003). The
genome is pivotal in that it contains all the instructions for assembling the particular
arrays of molecular machines that are characteristic for each species. More impor-
tantly, the genome also encodes the information that controls the way in which each
gene is expressed (turned on and oﬀ) in time and space, linking them into complex
regulatory networks. Such networks comprise two major constituents; (i) stretches
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makes, (ii) regulatory proteins that bind to these control regions and modulate their
activity. The combined activity of control regions and regulatory factors is at the
heart of the development and physiology that deﬁnes an organism (Hood & Galas,
2003). Thus, it is important to realise that the appearance and biology of a mature
organism is the result of a complex series of ontogenetic events unfolding over time,
moderated by environmental and stochastic inﬂuences. Genomes are much more like
knitting patterns or recipes than blueprints (although even the former are poor anal-
ogies for the peculiarities of the genome). The majority of the sequence of the human
genome has been determined, but it still harbours many surprises; for example it has
recently become clear that, in addition to the well-understood protein-coding genes,
genomes also encode a host of RNA transcripts that do not direct the synthesis of
proteins, but nevertheless play key roles in regulating cell behaviour (e.g. Kuwabara,
Hsieh, Nakashima, Taira, & Gage, 2004).
The ‘‘Human Genome Sequence’’ (Wolfsberg, McEntyre, & Schuler, 2001) is a
generalised description somewhat akin to anatomical annotations of the structure
of the organs and skeleton of the human body. On the basis of sequencing data,
the human genome contains 24–30,000 diﬀerent protein-encoding genes. (Remember
that the deﬁnition of a gene is a complex issue, and it can sometimes be hard to pre-
dict where a gene begins and ends, hence the continuing uncertainty over the exact
number of genes in the genome.) The vast majority of people have essentially the
same set of protein-encoding genes and regulatory regions (with a few exceptions,
which are not relevant to the present discussion). However, due to random muta-
tions, the actual nucleotide sequences tend to vary between individuals of the same
species in a given population. As a consequence diﬀerent people may have distinctive
versions of any particular gene, known as ‘‘alleles’’ or ‘‘allelic variants’’. Although
many allelic variants are functionally silent, meaning that they do not alter the result-
ing protein sequence, or the way that the protein is regulated, some variants lead to
functional changes. For example, a simple nucleotide change may alter the type of
amino acid at a deﬁned point within the encoded protein, modifying both its struc-
ture and function. Tiny sequence changes at the nucleotide level can even result in a
complete absence of protein function, for example by causing the amino acid chain
to be prematurely terminated. Allelic variants with such dramatic consequences for
protein function tend to be present at low frequency in the human population as a
consequence of negative selection and are responsible for classical single gene disor-
ders like Duchenne muscular dystrophy. However, alleles with more subtle eﬀects are
likely to be present at higher frequency, and could contribute to variability in com-
mon traits (Reich & Lander, 2001).3. The human geneticist’s toolkit
A central aim of modern human genetics is to determine the causal links between
genotype (the genetic makeup of an individual in terms of allelic variants) and phe-
notype (the appearance of an individual in terms of a particular characteristic, be it
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2003). In pursuing this aim, geneticists seek to address a number of separate, but
related, issues (Collins et al., 2003). At a clinical level, such eﬀorts hope to identify
the molecular basis of diseases and developmental disorders, and success in this area
can have obvious ramiﬁcations for diagnosis and intervention (Bell, 2003). Linking
genotype to phenotype is also essential if we are to understand how natural genetic
variation contributes to trait variability in normal populations (Freimer & Sabatti,
2003). At a more fundamental level, these kinds of studies promise to help uncover
the roles of diﬀerent genes in aspects of human biology, shedding light on embryonic
development, metabolism, immunity, tissue-speciﬁc functions and so on (Collins
et al., 2003). Thus, it can be argued that identiﬁcation of genetic variants predispos-
ing to syndromes like dyslexia, language impairment and autism will not only enable
us to improve diagnosis and treatment of these disorders, but could also give new
insights into normal cognitive processes and increase our understanding of molecular
pathways that impact on brain function (Fisher & Marcus, 2006; Marcus & Fisher,
2003).
When attempting to ﬁnd links between genotypes and phenotypes, researchers
have at their disposal a variety of methods and techniques, which are generally appli-
cable to any trait or gene of interest. In particular, ‘‘positional’’ strategies have
proved to be lucrative for a wide range of situations, since they can be successful
even in the total absence of any knowledge regarding the biological underpinnings
of a trait (Botstein & Risch, 2003). A typical study of this kind involves analyses
of the inheritance patterns of diﬀerent chromosomal regions in families aﬀected by
the trait being studied. Remember that every human being inherits two copies of
each of the nonsex chromosomes, one originating from the father (paternal) and
one originating from the mother (maternal). These copies will usually contain an
identical array of genes, but they may diﬀer with respect to the speciﬁc allelic variants
at each gene. The choice of chromosomal copy that is passed on to the next gener-
ation is essentially random, and each chromosome assorts independently of the oth-
ers. In addition, homologous (corresponding) sections of maternal and paternal
chromosome copies are sometimes exchanged during generation of germ cells
(oocytes/sperm) by a process called crossing over. The occurrence of crossing over
events is generally stochastic, although they can cluster in ‘‘hotspots’’, and the over-
all result is that corresponding sections of chromosomes are shuﬄed around from
generation to generation. This process of genetic recombination means that the
genomic make-up that is inherited by an individual can be viewed as a patchwork
of maternal and paternal alleles from previous generations (Pa¨a¨bo, 2003). It is the
patchwork nature of genomic transmission that allows geneticists to map allelic vari-
ants inﬂuencing a trait of interest to particular chromosomal intervals.
In practice this can be achieved by (i) identifying families containing individuals
aﬀected with a trait of interest, (ii) determining the inheritance patterns of each sec-
tion of chromosome within each family, and (iii) asking whether the inheritance of
any chromosomal interval is correlated (or ‘‘linked’’) with the inheritance of the
trait. Geneticists refer to this process as ‘‘linkage analysis’’. Positive correlations
may result from a real biological eﬀect (i.e. allelic variation of a gene mapping within
S.E. Fisher / Cognition 101 (2006) 270–297 275the chromosomal interval could be inﬂuencing the trait) but might also occur by
chance. Thus, it is necessary to perform statistical tests to assess how likely it is that
a linkage result is a chance ﬁnding (Lander & Kruglyak, 1995). Typically linkage
studies exploit naturally occurring variations in DNA sequence at a series of markers
along a chromosome. These markers do not need to be within genes or have any bio-
logical function; they are simply used as a means to track inheritance patterns, a way
of mapping out the patchwork of chromosomal chunks that get passed through a
family. A strength of linkage-based approaches is that by screening only a small
number of markers one can obtain a clear picture of the inheritance patterns within
a family; for example using only 400 markers it is possible to rapidly scan the entire
human genome (all 3 billion letters) for a genetic eﬀect on a trait of interest. The con-
comitant weakness is that, by themselves, these techniques are unable to exactly pin-
point the position of the putative genetic change that inﬂuences the trait, but instead
provide the ﬁrst clue to its location; regions implicated by linkage may contain tens
or even hundreds of genes, any of which might harbour the causative variant. Nev-
ertheless linkage analysis can often narrow the focus of the search quite substantially
(given that the full human genome may contain as many as 30,000 protein-encoding
genes). This approach has therefore played an extremely important role in helping to
identify the genes implicated in a large number of simple genetic disorders, and is
beginning to make its mark in more complex traits (Korstanje & Paigen, 2002).
Classical linkage analysis in humans relies on dichotomous classiﬁcation of
whether an individual is aﬀected or unaﬀected (referred to as ‘‘aﬀection status’’).
While this has proved a powerful tool under certain circumstances, there are often
diﬃculties with deﬁning disorder in complex behavioural or cognitive syndromes
(Fisher & DeFries, 2002; Fisher et al., 2003; Folstein & Rosen-Sheidley, 2001; Gri-
gorenko, 2001). Moreover, categorical diagnoses are unable to speak to genetic inﬂu-
ences on variability in the normal range. Many recent studies of complex human
traits have been able to move away from categorical deﬁnitions altogether, by using
quantitative-trait-locus (QTL) methods (Glazier, Nadeau, & Aitman, 2002). These
are similar to methods based on aﬀection status, in that they assess the signiﬁcance
of phenotype-genotype correlations for the chromosomal region under investigation.
However, they directly incorporate quantitative data (e.g. test scores obtained with
measures of cognitive ability) in the statistical analysis, rather than collapsing the
phenotype into the dichotomous status of aﬀected versus unaﬀected. The choice of
whether to use categorical deﬁnitions or quantitative traits depends to some extent
on the particular study design and the questions that are being asked; each approach
has its own strengths and weaknesses (see Fisher & DeFries, 2002; for more discus-
sion). For neurodevelopmental disorders, genome-wide scans for linkage have been
eﬀective in identifying chromosomal intervals that might be implicated in dyslexia
(de Kovel et al., 2004; Fagerheim et al., 1999; Fisher et al., 2002b; Kaminen et al.,
2003; Nopola-Hemmi et al., 2001), speciﬁc language impairment (Bartlett et al.,
2002; SLI Consortium, 2002) and autism (numerous scans including Buxbaum
et al., 2001; CLSA, 2001; IMGSAC, 1998, 2001; Philippe et al., 1999; Shao et al.,
2002; Yonan et al., 2003). These studies have used a mixture of diﬀerent approaches,
some employing categorical deﬁnitions, others relying on QTL-based methods. It is
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studies of complex traits. Independent replication is essential to support the robust-
ness of any proposed linkage, and there have been many cases where ﬁndings could
not subsequently be supported in separate datasets.
Higher resolution mapping of genetic eﬀects is feasible using methods based on
‘‘association’’. While linkage assesses marker-trait correlations within families, asso-
ciation evaluates whether there is a correlation between a particular allelic variant
and a trait at the population level (Cardon & Bell, 2001). One of the simplest study
designs for detecting association is to compare allele frequencies at a genetic locus in
aﬀected cases with those in unaﬀected controls. A higher frequency of an allele
among the cases might indicate that this variant acts as a risk factor for the disorder
(conversely a lower frequency could suggest a protective eﬀect). In a similar manner
to linkage, these methods have been extended for use with quantitative traits. As
with linkage, there is the danger that an allele-trait association arises due to chance,
so robust statistical analysis is again of the essence (Cardon & Bell, 2001). (Spurious
associations may also result from factors like population stratiﬁcation, which will
not be discussed here.) In addition, a signiﬁcant association does not necessarily indi-
cate that the allele in question is the aetiologically important variant; it may be due
to a phenomenon known as ‘‘linkage disequilibrium’’ in which neighbouring allelic
variants have travelled together during the recent evolutionary history of the popu-
lation. Association-based methods are very powerful for detecting small genetic
eﬀects, but are only sensitive if the marker under investigation maps close to the site
of the aetiological variant in the genome. In other words, if taking a purely position-
al approach to systematically scan the entire genome via association, one would have
to screen an unfeasibly large number of markers to be conﬁdent of ﬁnding a real
eﬀect. (Note, however, that as technology improves this is becoming less of a hurdle.)
Many researchers in the ﬁeld of complex traits are currently using a combined strat-
egy, in which the entire genome is screened via linkage, and then the implicated
regions are the focus of intensive association-based eﬀorts. For example, chromo-
somal intervals implicated by linkage studies of developmental dyslexia are now
being closely examined via high-throughput association analyses (e.g. Cope et al.,
2005a; Deﬀenbacher et al., 2004; Francks et al., 2002, 2004).
The study of gross chromosomal abnormalities represents another invaluable
method for making connections between genomic regions and particular traits. In
a small proportion of individuals, disorder is caused by disruption to genes as a con-
sequence of deletions, inversions, duplications or translocations of sections of chro-
mosomes. Well-characterised examples of the eﬀects of such abnormalities on brain
function include Down’s syndrome (Roizen & Patterson, 2003) and Williams syn-
drome (Morris & Mervis, 2000), but the total impact of sporadic chromosomal rear-
rangements on cognitive deﬁcits is unknown. Even when rearrangements are not
detected under the microscope, subtle abnormalities (e.g. submicroscopic deletions)
may be present; for example rearrangements of chromosome ends (telomeres)
account for a signiﬁcant proportion of cases of idiopathic mental retardation (Flint
& Knight, 2003). Investigation of chromosomal abnormalities can be particularly
powerful if they coincide with intervals already implicated by linkage in mapping
S.E. Fisher / Cognition 101 (2006) 270–297 277studies; however, the identiﬁcation of such cases depends to a large extent on seren-
dipity. In addition, many sporadic chromosomal rearrangements are benign, so that
their occurrence in aﬀected subject is sometimes coincidental rather than causal.
Nevertheless, this is an essential branch of genetics that is playing a major role in
our attempts to connect genes to cognition; for example studies of chromosomal
translocations provided the basis for the identiﬁcation of the DYX1C1 gene as a can-
didate for involvement in dyslexia (Taipale et al., 2003) and were also important in
the discovery of the role of FOXP2 in speech and language disorder (Lai, Fisher,
Hurst, Vargha-Khadem, & Monaco, 2001).
Attempts to connect speciﬁc phenotypes with distinct genotypes can also be
driven by hypotheses regarding the biological basis of a trait. In these cases, theories
regarding the aetiology of a disorder suggest particular processes or pathways, impli-
cating a gene or set of genes which can be considered as candidates. Direct associa-
tion analysis or mutation screening of a candidate gene may yield evidence
supporting involvement of that gene, and may also strengthen the case for the aeti-
ological hypothesis. This kind of approach has been extensively adopted for investi-
gating Attention Deﬁcit/Hyperactivity Disorder (ADHD), with candidate genes
being selected based on knowledge of eﬀective drug treatments (DiMaio, Grizenko,
& Joober, 2003), although complementary positional-based strategies are also begin-
ning to be used (Arcos-Burgos et al., 2004; Bakker et al., 2003; Fisher et al., 2002a;
Ogdie et al., 2003). For many neurodevelopmental phenotypes of interest, including
dyslexia, speciﬁc language impairment (SLI) and autism, we have highly limited
understanding of the likely molecular underpinnings. Thus, in these cases, pure can-
didate gene approaches (in absence of any positional information from linkage, asso-
ciation or chromosomal abnormality-based studies) have not yet been successful for
genetic dissection, while combined strategies appear to be more productive (e.g. see
dyslexia studies of Cope et al., 2005a; Francks et al., 2004; Taipale et al., 2003).4. Discarding the abstract gene: Acknowledging complexity and context
Equipped with the above tools of contemporary human genetics, researchers are
starting to make headway in the hunt for genetic variants that contribute to common
neurodevelopmental disorders of unknown aetiology. The present article does not
seek to provide yet another overview of all the molecular genetic results obtained
from these studies, since comprehensive accounts of progress in the ﬁelds of autism
(Folstein & Rosen-Sheidley, 2001; Wassink, Brzustowicz, Bartlett, & Szatmari,
2004), dyslexia (Fisher & DeFries, 2002; Fisher & Francks, 2006; Grigorenko,
2001) and speech and language disorders (Fisher et al., 2003) have been published
elsewhere. Moreover, I focus here on what we can learn about genes and cognition
from the point of view of human neurodevelopment. Investigations of neurodegen-
erative disease (such as the well characterised role of the APOE gene in dementia), or
genetic inﬂuences on normal cognitive function (e.g. potential eﬀects of BDNF gene
variants on memory processing) will not be discussed. For an insightful review of the
latter, readers are referred to Goldberg and Weinberger (2004).
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a number of key issues that have emerged from recent studies of neurodevelopmental
genetics, in particular those that illustrate the need to replace views based on ‘‘the
abstract gene’’ with more complex and realistic paradigms. The ﬁrst point is that
while the majority of common neurodevelopmental disorders are known to have a
signiﬁcant heritable component (based on twin and adoption studies), the genetic
contributions are largely multifactorial in nature. That is, in most cases the suscep-
tibility to these disorders will involve variants in multiple genes each with a small to
moderate eﬀect, modulated by the inﬂuences of environmental factors. Diﬀerent
clusters of genes may be implicated in diﬀerent aﬀected subjects (genetic heterogene-
ity) and increased risk might depend on interactions between several genes. Gene–en-
vironment interactions may also be critical for the manifestation of disorder. The
presence of this genetic complexity, which can obscure the connections between
genotypes and phenotypes, was initially suspected on the basis of epidemiological
studies, and has been strongly conﬁrmed by molecular mapping studies (Fisher &
DeFries, 2002; Fisher et al., 2003; Folstein & Rosen-Sheidley, 2001; Grigorenko,
2001). There are some notable rare exceptions; families which display apparently
simple monogenic (single gene) inheritance of neurodevelopmental impairment
(e.g. Fisher, Vargha-Khadem, Watkins, Monaco, & Pembrey, 1998) which I will dis-
cuss later.
The second issue worth highlighting is that while considerable progress has been
made in recent years in mapping genetic inﬂuences on common neurodevelopmental
disorders, the identiﬁcation of speciﬁc alleles that confer susceptibility remains prob-
lematic. Although other approaches are now coming to the fore, the majority of
investigations thus far have relied on linkage analyses. For example, linkage-based
studies of dyslexia have mainly implicated regions on chromosomes 1, 2, 3, 6, 15
and 18 (reviewed by Fisher & DeFries, 2002 & Grigorenko, 2001), while genome
screens in SLI point to potential loci on 13, 16 and 19 (Bartlett et al., 2002; SLI Con-
sortium, 2002). A few of the dyslexia linkages have shown consistency in indepen-
dent studies, to an extent that is unusual for a complex trait, suggesting that they
represent real eﬀects. Most notably, linkage to a region on the short arm of chromo-
some 6 has been supported in multiple datasets and analyses (e.g. Cardon et al.,
1994; Fisher et al., 1999; Gaya´n et al., 1999; Grigorenko et al., 1997; Kaplan
et al., 2002; Turic et al., 2003), although not every study has been able to replicate
(Field & Kaplan, 1998; Schulte-Ko¨rne et al., 1998). Nevertheless, unambiguous cases
of replicated linkages remain the exception. Consider the two independent SLI gen-
ome screens of Bartlett et al. (2002) and the SLI Consortium (2002); strong linkage
peaks were uncovered in each scan (chromosome 13 in the former, and chromosomes
16 and 19 in the latter) but there was virtually no overlap in ﬁndings from these two
large-scale studies. Moreover, despite overall advances in mapping, no study has yet
demonstrated a clear replicable eﬀect of one particular functional variant on a com-
mon form of neurodevelopmental disorder. The situation is promising for the case of
the dyslexia-related locus on chromosome 6, where independent association analyses
have converged on a small interval containing only a few genes (including KIAA0319
and DCDC2), but even then there is disagreement over which of these genes inﬂuenc-
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2005a; Deﬀenbacher et al., 2004; Fisher & Francks, 2006; Francks et al., 2004; Meng
et al., 2005). A handful of genes have been directly implicated in rare cases of neu-
rodevelopmental disorder, including FOXP2 in speech and language impairment
(Lai et al., 2001), neuroligins NLG3 and NLG4 in autism (Jamain et al., 2003) and
DYX1C1 and ROBO1 in dyslexia (Taipale et al., 2003; Hannula-Jouppi et al.,
2005). However, coding variants of FOXP2 have not been found in typical SLI
(Newbury, Bonora, Lamb, Fisher, & Lai, 2002; O’Brien, Zhang, Nishimura, Tom-
blin, & Murray, 2003), and the relevance of variants in NLG3, NLG4, DYX1C1
and ROBO1 for common disorders remains open to question (Cope et al., 2005b;
Gauthier et al., 2004; Hannula-Jouppi et al., 2005; Marino et al., 2005; Scerri
et al., 2004; Vincent et al., 2004; Wigg et al., 2004). More discussion regarding the
relationship between speciﬁc candidate genes (DYX1C1, KIAA0319, DCDC2 and
ROBO1) and dyslexia susceptibility can be found in Fisher and Francks (2006).
My third point expands on an aspect of genetic studies that I alluded to in previ-
ous sections of this article. Positional approaches have the advantage that they can
be carried out in total absence of any knowledge regarding aetiological mechanisms;
genotype can be connected to phenotype with no need for reference to biological or
developmental context. As our knowledge of the genome increases and genotyping
costs plummet, genetic investigations of human brain-related phenotypes are becom-
ing more and more widespread. The only caveat appears to be the need to demon-
strate with robust statistics that any correlations that are detected are unlikely to
be due to chance. Unfortunately, the ability to undertake genetic analyses while
employing only the most basic abstract concept of ‘‘the gene’’, and without any
understanding of molecular pathways, has become both a blessing and a curse, par-
ticularly in studies of the brain. The apparent ease of correlating genotype with phe-
notype without reference to molecular/developmental mechanisms promotes an
erroneous impression of neurogenetics; one in which individual genes are able to
mysteriously control speciﬁc behaviours or cognitive abilities, leading to talk of ‘‘lan-
guage genes’’, ‘‘smart genes’’, ‘‘gay genes’’, ‘‘aggressive genes’’ and so on. It is indis-
putable that variations of gene sequence can contribute to variability in cognitive
abilities and personality traits (sometimes in a dramatic manner) and that apparently
straightforward genotype-phenotype correlations can sometimes emerge in our data-
sets. But the simplicity of these relationships is merely an illusion; genes do not (and
indeed can not) specify particular behavioural outputs or cognitive processes, except
in the most indirect way. As highlighted by Inoue and Lupski (2003), assumptions of
simple linear relations between genes and cognitive/behavioural phenotypes have
impeded progress in the ﬁeld, and fuel hypotheses that must ultimately be untenable.
The gross activities of the human brain are the products of a complex interplay
between factors at multiple levels; be they genetic, cellular, developmental, anatom-
ical, or environmental, and the routes linking genes to cognition will inevitably be
tortuous (Marcus, 2003). It is worth noting that this is likely to apply even to sup-
posedly simple monogenic disorders of brain development, as I illustrate below with
the example of the FOXP2 gene. This is not to imply that any attempts to disentangle
links between genes and cognition are a waste of time. However, we ignore at our
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developmental context. Grant (2003) has similarly argued that the gap between genes
and cognition can only be bridged by a thorough systems biology account of brain
development and function.
Even pure candidate gene approaches can be victims of the ‘‘abstract gene’’ per-
spective. In many cases, when researchers ﬁnd statistical evidence to support associ-
ation between a particular variant of a gene and a common trait, it is erroneously
assumed on the basis of this that the variant is likely to be causative and that there
is a simple pathway connecting gene to trait. In studies of common human behav-
ioural/cognitive traits, it is rare to see experiments demonstrating that putative risk
variants actually do aﬀect the function or expression of candidate genes, although
investigators are beginning to remedy the situation (e.g. Kakiuchi et al., 2003). This
brings me on to my ﬁnal issue, which may be referred to as the ‘‘Are we there yet?’’
phenomenon (Page, George, Go, Page, & Allison, 2003). In single-gene disorders the
aetiological variants often have obvious and gross consequences for gene function;
for example via protein truncation or alteration of a critical functional domain. In
addition, the correlation between inheritance of these mutations and development
of the disorder in these cases usually approaches 100%. Under these circumstances
a geneticist can be conﬁdent that the cause of the disorder has indeed been pinpoint-
ed. (Note, however, that complementary functional data are invariably sought to
provide the ﬁnal proof.) For traits with a complex genetic basis, the connections
between gene variation and phenotype are much more diﬃcult to pin down; the risk
variant might be commonly found amongst unaﬀected individuals, absent from
many aﬀected individuals, and the consequences for expression or function of the rel-
evant gene could be subtle. Several neighbouring allelic variants may be in linkage
disequilibrium, each yielding signiﬁcant statistical evidence for association with the
trait of interest, so that it can be highly challenging to determine the identity of
the true functional variant (or indeed if the entire association is due to a false positive
result). This predicament is at the core of all attempts to genetically dissect complex
traits (Page et al., 2003). There is a large gulf between ﬁnding statistical evidence for
a genotype-phenotype correlation and demonstrating a convincing causal relation-
ship, and appreciation of the distinction is essential for those trying to interpret stud-
ies in this ﬁeld (Fisher & Francks, 2006).5. Dissecting disorders: Cautionary tales from studies of dyslexia
When searching for correlations between neurodevelopmental traits and geno-
types, the approach to phenotype deﬁnition is critical. In investigations of disorder,
a dichotomous classiﬁcation of aﬀected versus unaﬀected provides the most simple
basis for detecting linkage (identifying chromosomal intervals that are commonly
inherited by multiple aﬀected members of a family) or association (for example in
comparisons of allele frequencies in cases versus controls). However, there are often
diﬃculties associated with assigning aﬀection status in complex traits (Lander &
Schork, 1994). For disorders such as dyslexia, autism or SLI there can be consider-
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amongst diﬀerent aﬀected individuals (for reviews see Fisher & DeFries, 2002; Fisher
et al., 2003; Folstein & Rosen-Sheidley, 2001; Grigorenko, 2001). Moreover, the
same individual may show changes in phenotypic proﬁle at distinct points of his
or her development. Attempts to subdivide neurodevelopmental disorders into sep-
arable subtypes with clearly distinctive aetiologies have met with only limited suc-
cess. A number of complementary strategies have been employed to handle issues
of phenotypic complexity for genetic analyses, and studies of dyslexia provide some
apt illustrations.
One approach is to decompose the phenotypic proﬁle that is associated with the
disorder into diﬀerent features, initially referred to in the literature as ‘‘components’’
(Grigorenko et al., 1997). The nature of so-called components is essentially driven by
hypotheses regarding potential cognitive bases of disorder. The most overt charac-
teristics of dyslexia are impairments in reading and/or spelling that are not attribut-
able to general intellectual delay or inadequate environmental stimulation (Habib,
2000). However, it has been robustly shown that most aﬀected individuals have sig-
niﬁcant linguistic deﬁcits even when performing tasks that do not involve any read-
ing or writing (Snowling, 2001). There has thus been much focus in recent years on
tests that tap into hypothesized phonological processing pathways which appear to
be impaired in subjects with dyslexia. These include phoneme awareness, deﬁned as
the ability to explicitly manipulate the separate speech units that make up a word. In
addition, many individuals with dyslexia manifest diﬃculties when rapidly naming
sequences of objects, colours, shapes and so on (Wolf & Bowers, 2000). Hypothetical
phenotypic components have also been derived from models describing the cognitive
underpinnings of normal reading. A relevant example is the dual-route model, which
proposes that the mature reader has available two alternative routes for reading a
visually presented word. One (phonological decoding) involves the separation of
the written word into constituent grapheme units and conversion of these to appro-
priate phonemes, while the other (orthographic coding) requires recognition of the
entire word and retrieval of the appropriate phonological representation from a
mental lexicon (Castles & Coltheart, 1993). It has been argued that decoding of pro-
nounceable nonsense words (nonwords) should primarily tap the putative phonolog-
ical route, while accurate reading of irregular words (those that violate standard
grapheme–phoneme conversion rules, like ‘‘colonel’’ or ‘‘yacht’’) will predominantly
involve orthographic processing. Questions regarding the validity of dual-route
models of reading will not be discussed here. The key point is that theories of normal
and abnormal reading processes have led geneticists to explore phenotypes such as
phoneme awareness, phonological decoding, orthographic coding and rapid auto-
mised naming in families aﬀected with dyslexia. Note that although the phenotypes
used in these studies have been termed ‘‘components’’ of dyslexia, they do not rep-
resent fully independent constituents of the cognitive proﬁle; Grigorenko et al.
(1997) described them as ‘‘more precise deﬁning attributes, partly overlapping but
partly distinct’’. Indeed, there tend to be moderate to high correlations between
the diﬀerent language- and reading-related measures that are used as indices of puta-
tive components; for example nonword reading and irregular word reading, often
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respectively, show correlations of 0.57–0.61 in one large set of families (Marlow
et al., 2001). A small proportion of individuals appear to show dissociation between
nonword reading and irregular word reading ability, leading to suggestions of pho-
nological- and surface-dyslexia subtypes (Castles & Coltheart, 1993), but in most
subjects with dyslexia, deﬁcits are observed for both nonword and irregular word
reading.
The strategy exempliﬁed by the work of Grigorenko et al. (1997) involves multiple
sets of genetic analyses of the same families under a series of diﬀerent diagnostic
schemes, each tapping one of the above-mentioned hypothetical components. Thus,
one set of analyses might assess phenotype–genotype correlations for an aﬀection
status based on impaired phoneme awareness, another might look at the phenotype
of phonological decoding, while a third might examine deﬁcits in rapid automised
naming. It is worth highlighting that this is somewhat diﬀerent from studying sepa-
rate subtypes, since the components are partly overlapping e.g. some individuals
within a family might be considered as aﬀected only for phoneme awareness, others
might be aﬀected for both phoneme awareness and phonological decoding, and so
on. Most importantly there are usually members of families who are not considered
to be dyslexic, but do show deﬁcits on one or more of the putative component phe-
notypes (Grigorenko et al., 1997). Thus, Grigorenko and colleagues were able to
address phenotypic complexity while continuing to exploit the power and simplicity
of categorical deﬁnitions. It is also possible to carry out this kind of phenotypic frac-
tionation within a QTL-based framework; for example studies have looked directly
for correlations between genotypes and quantitative test scores tapping each hypoth-
esized phenotypic component (phoneme awareness, phonological decoding, etc.) in
families with dyslexia (Fisher et al., 1999; Gaya´n et al., 1999). QTL methods allow
all phenotyped individuals from a pedigree to be incorporated into the analysis
regardless of aﬀection status, but the initial ascertainment of families still relies on
diagnostic criteria (Fisher & DeFries, 2002).
What have we learned about the genetic basis of dyslexia by fractionating the
overall phenotype into hypothetical components? In their pioneering study, Gri-
gorenko and colleagues (1997) analysed six extended families under diﬀerent categor-
ical classiﬁcation schemes representing phenotypes of phoneme awareness,
phonological decoding, rapid automised naming, single-word reading, and IQ-read-
ing discrepancy. They targeted two chromosomal regions for investigation, one on
chromosome 6 and the other on chromosome 15, because these had been suggested
by previous genetic studies (Cardon et al., 1994; Smith, Kimberling, Pennington, &
Lubs, 1983), and assessed linkage to each phenotype in their families. Intriguingly
the pattern of results with respect to phenotype deﬁnitions diﬀered for the two loci;
chromosome 6 gave strongest evidence of linkage to impairments in phoneme aware-
ness, while chromosome 15 results were most signiﬁcant for deﬁcits in single-word
reading. Such a dissociation of genetic inﬂuences might be taken to imply existence
of a ‘‘phoneme awareness gene’’ on chromosome 6 and a ‘‘single-word reading gene’’
on chromosome 15, suggesting that we will ultimately be able to dissect the overall
dyslexia phenotype into component-speciﬁc genetic eﬀects each localised to a diﬀer-
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between speciﬁc genes and certain cognitive processes, after all?
In attempting to answer this question, various authors have raised methodologi-
cal issues regarding the apparent dissociation of genetic eﬀects observed by Gri-
gorenko et al. (1997); these are of a technical nature and the interested reader is
referred to other publications for more details (Field & Kaplan, 1998; Fisher
et al., 1999; Fisher & DeFries, 2002; Pennington, 1997). However, beyond the tech-
nical caveats that are peculiar to that study, any genetic analysis of dissected pheno-
types encounters general constraints that must limit the conclusions we are able to
draw. The main problem is that genotype-phenotype correlations can be inﬂuenced
by many factors that are unrelated to the magnitude of the underlying genetic eﬀects
(Fisher & DeFries, 2002; Marlow et al., 2003). These other factors include the sen-
sitivity of diagnostic instruments, the shape of the distribution of test scores, the ages
of aﬀected/unaﬀected individuals and ﬂuctuations in sample size under diﬀerent
diagnostic schemes. Thus, when the same set of families (or individuals) is studied
using multiple diﬀerent, but related, phenotypes it is diﬃcult to be sure that changes
in the apparent signiﬁcance of genotype-phenotype correlation truly reﬂect aetiolog-
ical diﬀerences at the molecular level. This applies regardless of whether phenotypes
are deﬁned in a categorical manner or as fully variable quantitative traits.
The bottom line is that the sample sizes of studies to-date (typically involving hun-
dreds of subjects) may be suﬃcient for detection of complex genetic eﬀects, but they
lack adequate power for determining the relative eﬀect sizes of genes on diﬀerent
measures or phenotypes. As a consequence the proﬁle of results associated with link-
age at a particular chromosomal locus can shift substantially with the addition of
more families/subjects to the sample. Notably, expansion of the original Grigorenko
et al. (1997) sample led to a reversal of the original pattern of results on chromosome
6, such that single-word reading yielded the most signiﬁcant linkage while phoneme
awareness became the weakest-linked phenotype (Grigorenko, Wood, Meyer, &
Pauls, 2000), which is of course incompatible with the view that this locus harbours
a gene that speciﬁcally impacts on phoneme awareness. In addition, studies of other
sets of families have provided support for linkage or association on chromosomes 6
and 15, but do not ﬁnd component-speciﬁc eﬀects for either putative risk locus (Def-
fenbacher et al., 2004; Fisher et al., 1999, 2002b; Francks et al., 2004; Gaya´n et al.,
1999; Kaplan et al., 2002; Schulte-Ko¨rne et al., 1998; Turic et al., 2003). For example
independent QTL-based studies have replicated linkage to the chromosome 6 locus,
but implicated multiple reading- and language-related measures, including phoneme
awareness, phonological decoding and orthographic processing (Fisher et al., 1999;
Gaya´n et al., 1999). Similarly, association analyses of this locus point to eﬀects that
impact on multiple measures (Deﬀenbacher et al., 2004; Francks et al., 2004; Kaplan
et al., 2002; Turic et al., 2003).
The mapping of a putative susceptibility locus on chromosome 18 provides anoth-
er compelling example of the potential hazards involved when interpreting data from
multiple phenotypes. In a QTL-based genome-wide scan of dyslexia families from
the UK, the strongest evidence for linkage was found in a region on the short arm
of chromosome 18 (Fisher et al., 2002b). At this locus, results were highly signiﬁcant
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study, including spelling, phoneme awareness, phonological decoding and ortho-
graphic processing. Thus, at ﬁrst glance it might have been tempting to speculate
that this chromosome-18 locus harbours a gene with speciﬁc eﬀects on single-word
reading. In an independent sample of UK families, strong linkage was again seen,
to the same region of chromosome 18. However, in this replication sample results
were highly signiﬁcant for the measure of phoneme awareness and weaker for the
other measures, with least convincing results for single-word reading. Such a ﬁnding
argues against speciﬁcity of the locus, but, more fundamentally, it raises the question
of whether the results from this second sample do in fact constitute replication of the
linkage observed in the ﬁrst sample. These issues were explored in a follow-up study
by Marlow and colleagues (2003) who developed a multivariate approach which was
able to consider linkage to multiple measures simultaneously. Bivariate and multi-
variate quantitative analyses of twins had previously proved to be a valuable tool
for estimating the overall extent to which diﬀerent aspects of cognitive ability may
share common genetic (and environmental) inﬂuences (Gaya´n & Olson, 2001; Hoh-
nen & Stevenson, 1999). Marlow et al. (2003) extended standard multivariate
approaches to facilitate linkage testing of genomic loci in samples of sibling pairs;
the covariance between correlated measures is directly incorporated into the linkage
analysis, which can yield power gains over comparable univariate methods. Crucial-
ly, multivariate linkage methods allow formal assessments of the eﬀect for each trait,
considered simultaneously in the context of all other measures, and thus aid in deﬁn-
ing which traits contribute to the linkage or replication of a region. Marlow et al.
(2003) reanalysed the data from Fisher et al. (2002b) in a multivariate framework
and found that (i) the chromosome 18 locus was indeed strongly supported by both
the ﬁrst and second datasets, and (ii) in each case multiple measures were contribut-
ing to linkage.
As mentioned above, as well as chromosomes 6, 15 and 18, mapping studies have
implicated potential risk loci inﬂuencing dyslexia in several other genomic regions
(e.g. de Kovel et al., 2004; Fagerheim et al., 1999; Fisher et al., 2002b; Nopola-Hem-
mi et al., 2001; Kaminen et al., 2003; Tzenova, Kaplan, Petryshen, & Field, 2004).
Critically, as yet no study has identiﬁed a locus with a robust component-speciﬁc
inﬂuence. This is also the case for investigations of SLI; studies of families with
SLI have identiﬁed signiﬁcant linkage of a region on chromosome 16 to repetition
of nonsense words, but not to standardised scales assessing overall language (expres-
sive or receptive), which might suggest a component-speciﬁc eﬀect (SLI Consortium,
2002). However linkage was also observed at this same locus for measures of reading
and spelling in the same sets of families, supporting a more complicated picture (SLI
Consortium, 2004). Of course this does not mean that pure component-speciﬁc
eﬀects will never be discovered, although my guess is that this is unlikely in light
of what we already know about molecular genetic systems and the developmental
biology of the brain. I should emphasise that I am not arguing here for some kind
of genetically encoded ‘‘g-factor’’ for reading and/or language. Even in the absence
of straightforward component-speciﬁc eﬀects, it is reasonable to expect that allelic
variation in diﬀerent genes may contribute diﬀerentially to variability in alternative
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impact on phoneme awareness than on phonological coding). However, the clear
message from studies of dyslexia is that comparison of univariate linkage results
for multiple related traits is inadequate for assessing the true contributions of a locus
to diﬀerent aspects of a disorder. Multivariate linkage methods go some way towards
addressing this, but even with the availability of the latter, accurate quantiﬁcation of
eﬀect sizes remains something of a challenge. We may need to identify the functional
risk variants at each locus and recruit substantially greater numbers of families (per-
haps thousands) before we can properly answer these kinds of questions.
Before leaving this discussion, it is worth stressing again that while the measures
used in studies of dyslexia may hopefully take us closer to the biological basis of dis-
order, they are not necessarily pure indices of speciﬁc cognitive processes or the
activities of individual sets of neural circuits. As noted by Goldberg and Weinberger
(2004), the way in which we parse cognitive processes for our phenotypic studies will
seldom accurately reﬂect the underlying genetic architecture. This represents a fur-
ther level of complexity, over and above molecular and developmental constraints,
that should be taken into account when formulating theories based on genetic
dissection.6. The genetics of language: Debunking the ‘‘grammar gene’’ myth
Perhaps the best illustration of the pitfalls associated with an abstract view of the
gene revolves around the controversy of so-called ‘‘grammar genes’’ – genes that are
speciﬁc to aspects of human grammatical ability. Most debates regarding the sup-
posed existence of such genes have been conducted in ﬁelds outside molecular genet-
ics or developmental biology and have thus made little or no reference to the
inherent limitations and complexities of molecular systems. Research in the area
of linguistics ﬁrst led to the proposal of an innate ‘‘universal grammar’’ constraining
the structures of human languages (Chomsky, 1980). Deﬁning the molecular and/or
neural bases of this has since become something of a holy grail for the cognitive sci-
ences (Marcus, Vouloumanos, & Sag, 2003). In the early 1990’s there was widely
publicised media coverage regarding one large three-generational family (known
as KE) in which many members suﬀered from a purportedly grammar-speciﬁc disor-
der, apparently explained by a single gene. This was predominantly based on a short
correspondence published in Nature (Gopnik, 1990), which reported that aﬀected
family members were unable to infer general rules about signiﬁers of grammatical
features (a deﬁcit referred to as ‘‘feature blindness’’). Gopnik commented that these
deﬁcits ‘‘show up in spontaneous speech, writing, grammatical judgement and repe-
tition’’, suggesting that ‘‘the roots probably lie in the underlying grammar’’ and fur-
ther noted that the inheritance pattern indicated involvement of just one gene. It is
not surprising that this brief report received such a large amount of attention; it was
perceived by some as the ﬁrst hard evidence that human beings possess genes that
specify particular aspects of grammar, substantiation of a solid biological basis for
linguistic concepts of universal grammar. Despite the fact that the gene causing
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the discovery of a ‘‘grammar gene’’ (for further details see Pinker, 1994).
Over a decade later, we now know the identity of the gene that is damaged in
aﬀected members of this family, and are beginning to piece together what it does
at molecular and developmental levels (Lai et al., 2001; Lai, Gerrelli, Monaco, Fish-
er, & Copp, 2003). Thus, for the ﬁrst time, we are in a good position to connect
hypotheses originating in linguistics with data based on molecular/developmental
genetics. There is no doubt that the gene (known as FOXP2) is relevant to linguistic
ability. However, as I will illustrate below, any characterisation of this as a ‘‘gene for
grammar’’ (or even as a ‘‘gene for language’’) clearly becomes untenable once we are
able to view it within a more complete biological framework. Furthermore, we also
now understand much more about the nature of the disorder observed in the KE
family. A series of detailed studies have indicated that deﬁcits in grammatical ability
of aﬀected family members are just one aspect of a multifaceted disorder of speech
and language (Gopnik & Crago, 1991; Ullman & Gopnik, 1999; Vargha-Khadem,
Watkins, Alcock, Fletcher, & Passingham, 1995; Vargha-Khadem et al., 1998; Wat-
kins, Dronkers, & Vargha-Khadem, 2002). A profound feature of the disorder is a
diﬃculty in coordinating the complex sequences of mouth movements underlying
speech, and this is accompanied by wide-ranging linguistic and grammatical impair-
ment. In reactions to the popular myth that the KE family disorder is grammar-spe-
ciﬁc, it has sometimes been suggested that the disorder is either (i) simply a
generalised movement disorder with only secondary eﬀects on language/grammar
or (ii) a form of mental retardation aﬀecting both verbal and nonverbal domains.
However, these perspectives of the phenotype underplay the importance of linguis-
tic/grammatical features to an inappropriate extent; the true picture lies somewhere
in the middle of these extreme views (Marcus & Fisher, 2003). The disorder associ-
ated with FOXP2 disruption aﬀects speech, language and grammar; neither general
cognitive deﬁcits nor a basic motor deﬁcit can convincingly account for the proﬁle of
impairments, and neuroimaging indicates unambiguous functional abnormalities in
neural circuitry related to language processing (Liegeois et al., 2003). I will not dwell
further on the issue of phenotypic characterisation here, for more comprehensive dis-
cussion the reader is referred to reviews by Fisher et al. (2003), Marcus and Fisher
(2003) and Vargha-Khadem, Gadian, Copp, and Mishkin (2005).
Despite the multifaceted nature of the phenotype, the inheritance of disorder in
the KE family suggested involvement of only a single gene, facilitating the use of
a standard positional strategy to track down its identity. In 2001, Lai and colleagues
reported that a change to a single nucleotide in one copy of the FOXP2 gene on chro-
mosome 7 was responsible for the speech and language problems of the aﬀected KE
individuals. They also identiﬁed an unrelated subject with speech and language
impairment resulting from a translocation disrupting the FOXP2 locus (Lai et al.,
2000; Lai et al., 2001). Although at the time of its discovery FOXP2 was a novel
human gene (in that nobody had previously reported its full coding sequence) it
was possible to make predictions about the gene’s likely function by comparing it
to other genes that had already been characterised. This comparison revealed that
FOXP2 codes for a type of regulatory protein, called a transcription factor, which
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et al., 2001). As I explained earlier in this article, genomic biology is characterised
by regulatory networks involving control regions in genes and regulatory factors that
bind to them. This feature allows a static linear genome to encode the dynamic adap-
tive systems underlying the development and functions of a complex living organism
(Hood & Galas, 2003). The FOXP2 protein belongs to a subclass of transcription
factors known as forkhead proteins (Carlsson & Mahlapuu, 2002), each of which
contains a DNA-binding domain (called a ‘‘forkhead-box’’ domain) with a charac-
teristic structure. The human genome codes for more than 40 diﬀerent types of fork-
head protein, and these are involved in a wide variety of developmental and
physiological pathways (Carlsson &Mahlapuu, 2002). Of note, many forkheads play
important roles in controlling genetic cascades during embryonic development and a
number are critical for normal patterning of the central nervous system (CNS).
So how does the discovery of FOXP2 help to account for the disordered speech
and language abilities observed in the KE family? Aﬀected KE individuals have a
mutation that changes an amino acid at one point of the DNA-binding domain in
the FOXP2 protein (Lai et al., 2001). This alteration probably interferes with the
function of the mutated protein, so that it is not able to regulate its target genes
properly. Note that the disorder in the KE family is dominant, i.e. aﬀected members
have one mutant copy of FOXP2, and one normal copy. Thus, the speech and lan-
guage problems appear to be associated with reduced levels of functional FOXP2
protein in the brain (rather than a total absence of FOXP2 altogether). Recently,
MacDermot et al. (2005) identiﬁed a diﬀerent point mutation in multiple aﬀected
members of a newly identiﬁed family with speech and language disorder. In this case,
the mutation produces a ‘‘stop’’ signal in the middle of the FOXP2 protein, severely
truncating it, and presumably leading to loss of function. Again these individuals
carry one normal copy of FOXP2 and one copy that is mutated. Similar observations
come from studies of chromosomal rearrangements involving FOXP2; disruption of
only one copy of FOXP2 is enough to lead to speech and language impairment. Per-
turbed development due to reduced gene dosage (called ‘‘haploinsuﬃciency’’) is
often seen with other developmental disorders associated with transcription factor
disruption (Lehmann, Sowden, Carlsson, Jordan, & Bhattacharya, 2003). For exam-
ple, a range of diﬀerent mutations in a forkhead gene called FOXC1 cause disorders
of eye development, via the same kind of haploinsuﬃency mechanism (Saleem,
Banerjee-Basu, Berry, Baxevanis, & Walter, 2003). Patients with FOXC1 mutations
still have one intact copy of FOXC1, but the amount of functional FOXC1 protein
made by that is not enough for normal eye development.
It is reasonable to conclude from the above studies that reduced amounts of func-
tional FOXP2 protein can lead to disordered brain development or function, in a
manner that primarily interferes with speech and/or language abilities. This may well
give us clues to the usual function of FOXP2 in the normal CNS, and perhaps lead to
new insights into molecular pathways involved in speech and language acquisition.
However, it is essential to realise that this is emphatically not the same as saying that
FOXP2 is a ‘‘gene for speech’’ or a ‘‘gene for language’’, that its raison d’etre is to
provide humans with speech/language abilities. This is not merely a question of
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as I expand on at the end of this article. The invalidity of the ‘‘language gene’’ /
‘‘speech gene’’ tag becomes even more apparent as we consider additional features
of the gene that have been uncovered. First, FOXP2 mutation (although not restrict-
ed to the KE family) accounts for only a small proportion of cases of disordered
speech and language (MacDermot et al., 2005). Second, FOXP2 is not unique to
humans, and is found in extremely similar form throughout mammalian species
(Enard et al., 2002; Zhang, Webb, & Podlaha, 2002). The protein encoded by the
mouse version of this gene diﬀers from the human protein at only three amino acid
positions out of more than 700. Since mice clearly lack linguistic capabilities, the
remarkably high conservation of FOXP2 across the species is incompatible with
the idea that the gene exists solely to subserve the capacity for speech and language.
In other words, we can conclude that functional FOXP2 protein was already present
in the common nonlinguistic ancestor of humans and rodents over 70 million years
ago in a very similar form to that found in modern humans. Third, studies examining
the expression of FOXP2 (i.e. when and where it is switched on during development
and in adulthood) indicate that its functional importance is not restricted to the CNS
(Shu, Yang, Zhang, Lu, & Morrisey, 2001). The way that the patterns of gene
expression unfold in the developing embryo suggests that FOXP2 regulates key path-
ways in the developing lung, heart and gut. For example, in the developing lung,
expression of the gene becomes restricted to the distal airway epithelium, and exper-
iments have shown that it is able to regulate other genes that are important for lung
function (Shu et al., 2001). The recycled use of the same regulatory factors to control
multiple pathways in diﬀerent developmental contexts is a common feature of com-
plex biological systems; it is rare to ﬁnd a transcription factor that has an exclusive
role speciﬁc to only one context. Thus, calling FOXP2 a ‘‘language gene’’ makes no
more sense than referring to it as a ‘‘lung gene’’ or a ‘‘distal airway epithelium gene’’.
Fourth, detailed studies of FOXP2 in the brain indicate complexities of expression
even when we limit our examination just to the CNS. In both humans and rodents,
the gene is switched on in a range of brain regions during early development, includ-
ing cortex, thalamus, hypothalamus, striatum, cerebellum and medulla, and expres-
sion persists into adulthood (Ferland, Cherry, Preware, Morrisey, & Walsh, 2003;
Lai et al., 2003; Takahashi, Liu, Hirokawa, & Takahashi, 2003). A naı¨ve view of
a gene that exists to provide us with linguistic capabilities would predict an expres-
sion pattern that is restricted to a region of the brain such as Broca’s area.
In sum, much of the data on FOXP2 from molecular and developmental biology
confounds any expectations that one might have for a hypothetical ‘‘language gene’’;
and the reason for this is that this entire concept is ﬂawed, being rooted in an abstract
view of the nature of the gene.FOXP2 is a well conserved regulatory genewithmultiple
roles during development (and perhaps also in adulthood) and is likely to inﬂuence pat-
terning/function of several regions of the CNS in all mammals (Lai et al., 2003). Nev-
ertheless it is essential to emphasise that the above considerations do not diminish the
signiﬁcance of this gene for understanding molecular pathways underlying speech and
language (Marcus&Fisher, 2003). Rather, they provide a case-study showing that bio-
logical systems do not conform to the view of a simple relationship between genes and
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does not mean that the systems are impenetrable; instead we can begin to incorporate
molecular and developmental complexity into our models of what FOXP2 does. For
example, although the gene is indeed switched on in several areas of the developing
and mature CNS, detailed evaluation indicates that the expression pattern is tightly
regulated in each region. Expression is highest in the deep layers in the cortex, the stri-
osomal compartment in the striatum, the Purkinje cells and deep nuclei in the cerebel-
lum and the inferior olives in the medulla, and the timing of onset suggests a role in
neuronal development that is post-proliferation/migration in these regions (Ferland
et al., 2003; Lai et al., 2003; Takahashi et al., 2003). These ﬁndings are compatible with
the hypothesis that FOXP2 helps to establish and maintain connectivity of corticostri-
atal and olivocerebellar neural circuitry. (This idea is currently speculative, but is one
that can actually be tested in future in animal models using standard approaches of
molecular neuroscience.) The concordance between rodent and human expression pat-
terns suggests that FOXP2 was already playing such a role in the common ancestor of
these species (Lai et al., 2003).
Despite the high conservation of FOXP2 coding sequence among mammals, and
the strong likelihood that the gene was involved in patterning corticostriatal/olivo-
cerebellar circuitry many millions of years before the emergence of speech and lan-
guage, there is intriguing evidence that modiﬁcations of the gene may have been
selected in recent human evolution (Enard et al., 2002; Zhang et al., 2002). Of the
three amino acid changes that distinguish the mouse and human versions of the
FOXP2 protein, two occurred on the human lineage after the split between humans
and chimps, and statistical analyses suggest that these arose and rapidly spread
through the human population at some point within the last 200,000 years. The tim-
ing of this is concordant with estimates for the emergence of human speech and lan-
guage (around 50,000–100,000 years ago) (Boyd & Silk, 2000). These data have led
to something of a resurgence of the ‘‘speech gene’’/‘‘language gene’’ tag in the media,
a common theme being that tiny substitutions created radical changes in FOXP2
function and were the major driving force behind the evolution of human speech
and language. Again, consideration of the molecular and developmental context
argues against this extreme viewpoint. At present there is nothing known about
the functional signiﬁcance of the two amino acid changes that occurred on the
human lineage; they lie outside the well-characterised domains of the protein. The
inference of functional signiﬁcance is primarily based on statistical analyses of
sequence diversity. One of the changes has the potential to create a new site for reg-
ulation of the protein by other proteins; however, no-one has yet tested this hypoth-
esis directly, and in fact this same change occurred independently in carnivores
(Zhang et al., 2002), which is diﬃcult to reconcile with the idea that its appearance
in humans was the driving force for speech and language evolution. It is also worth
remembering that the human-speciﬁc version of FOXP2 is still essential for develop-
ment of other tissues outside of the brain (Lai et al., 2001), so any modiﬁcations
should have preserved the ‘‘original’’ functions of the gene to a large extent.
Integration of all the FOXP2 ﬁndings supports a nonsensational, but still tantaliz-
ing, picture of the recent evolution of this gene. It is reasonable to assume that FOXP2
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CNS of our nonlinguistic ancestors. It has long been known that these distributed cir-
cuits are critical for complexmotor control. There is an emerging consensus in the ﬁeld
of neuroscience that they are also key for aspects of cognition, such as procedural learn-
ing, deﬁned as the unconscious acquisition of skills through practice (Middleton &
Strick, 2000; Welsh, Lang, Suglhara, & Llinas, 1995). At a time when vocal communi-
cation was emerging in humans (for other undetermined reasons, be they genetic and/
or environmental), changes in FOXP2 which improved motor sequencing and/or pro-
cedural learning abilities (via modiﬁcations to corticostriatal/olivocerebellar pattern-
ing) might have given those humans possessing them a selective advantage. Thus,
given an environment in which vocal communication was becoming important, the
changes would have rapidly spread through the population. In such an environmental
context, a signiﬁcant selective advantage may have resulted from only subtle tweaking
of existing pathways (e.g. increased connectivity of corticostriatal circuits). Remember
that radical changes to FOXP2 would be unlikely to preserve its critical role in other
tissues (Lai et al., 2001; Shu et al., 2001), and thus might be lethal in the homozygous
state (i.e. when both copies of FOXP2 are altered). Of course, we will probably never
really know the true course of events that gave rise to ﬁxation of the modern human
version of FOXP2; the reasons for selection may not have related to speech and lan-
guage at all (Lieberman, 2002). However, to mymind, the model I have described here
is the most parsimonious based on current knowledge.
There remain many open questions regarding the role of the FOXP2 gene, which lie
beyond the scope of the present article. The most prescient point of this story is that
researchers now have the means to directly address many of the relevant issues via
molecular and developmental studies, and can attempt to formally integrate any ﬁnd-
ingswith those from investigations at other levels (e.g. neuroimaging, psycholinguistics
etc.). For example, there are intriguing concordances between the regions of expression
of FOXP2 (Lai et al., 2003) and adult sites of brain pathology revealed by structural
and functional neuroimaging (Liegeois et al., 2003; Vargha-Khadem et al., 1998).
Moreover, both approaches support the suggestion from the ﬁeld of cognitive sciences
that theKE family disorder involves deﬁcits in procedural learning (Ullman&Gopnik,
1999), although it is still unclearwhether suchdeﬁcits explain all the linguistic problems
of aﬀected individuals. Finally, the complexity of expression patterns may help to
account for the fact that FOXP2 disruption leads to impairment in multiple aspects
of CNS function (involving multiple brain regions). This suggests an interesting possi-
bility; even thoughwe know the primary genetic cause of the disorder, theremay not in
fact be a single identiﬁable core deﬁcit at the neurological level.7. The language of genetics: Concluding remarks
Looking to the future, it is apparent that the integrated eﬀorts ofmultiple disciplines
hold great promise for mapping the connections between genes and cognition (Gri-
gorenko, 2001;Hauser, Chomsky, &Fitch, 2002). For this to be fruitful, it is important
that scientists who are already experts in their own ﬁelds acquire at least a basic ﬂuency
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limitations of diagnosing neurodevelopmental disorders, the ways that cognitive phe-
notypes are parsed at the neuropsychological level, and the conclusions that may be
drawn from neuroimaging studies; linguists need to understand the routes by which
genetic eﬀects can bemapped and appreciate the restrictions imposed bymolecular sys-
tems; and so on. This will require some extra eﬀort, but all may then reap the beneﬁts
oﬀered by a truly holistic view of neural development and function.
The common feature of the examples that I have presented in the current article is a
misconception of simple linear relations between genes and behavioural or cognitive
outputs. The misconception is fuelled in part by a language barrier between the diﬀer-
ent ﬁelds.Geneticists routinely use the ‘‘gene forX’’ phraseology as a convenient short-
hand to describe their results. It is easier to refer to the ‘‘gene for cystic ﬁbrosis’’ than
‘‘the chloride channel gene which when it is mutated gives rise to cystic ﬁbrosis’’. Sim-
ilarly, when geneticists talk about an ‘‘asthmagene’’ in a commonpopulation they real-
ly mean ‘‘a gene, allelic variants of which inﬂuence a person’s risk of developing
asthma’’. It is clear that this kind of terminology has considerable value in that it sim-
pliﬁes communication within the ﬁeld, and it is important for increasing public aware-
ness regarding genetic contributions to traits, where references to complexity can
become ineﬀective. Nevertheless, I suggest that the common use of phrases like ‘‘gene
for dyslexia’’ and ‘‘language gene’’ has helpedmany of those outside ofmolecular ﬁelds
to come to erroneous conclusions. I am not proposing that such phrases have no value
and should be outlawed, but for those researchers seeking to unite genetics and cogni-
tion, I urge the following. First, geneticists should aim for increased clarity when
reporting their results in order to avoid misinterpretation by others, and second, non-
geneticists should aim to become familiar with the language of genetics, including all
the caveats that accompany the phrase ‘‘a gene for X’’.
I have implied here that many scientists investigating cognition are currently
happy to view genes as abstract entities, without much concern for the biological
mechanisms by which genes act to inﬂuence brain development or function. It
could be argued that this is an unfair criticism, since, in general, the functional
genetic variants inﬂuencing common forms of neurodevelopmental disorder are
unknown. Perhaps researchers do become interested in molecular systems and
developmental constraints, but only once the relevant genes themselves are clearly
known. This argument seems persuasive, but misses the point somewhat. Of
course it is unreasonable to expect scientists to grasp the molecular minutiae
underlying reading dysfunction (say) prior to conﬁrmation of the key genetic
players. However it is important to distinguish this kind of speciﬁc mechanistic
understanding from a broader appreciation of the general ways that genes are
able to function to help build and maintain a working brain. A basic knowledge
of what genes can and cannot do is necessary to constrain and inform hypotheses
about how genetic variability may relate to cognitive variability (whether in the
normal range or with respect to disorder). Crucially, such hypotheses can actually
play a fundamental role in our gene searches. For example, if researchers had
adopted a human-speciﬁc ‘‘language gene’’ view when searching for the molecular
basis of disorder in the KE family, then they may well have discounted FOXP2 at
292 S.E. Fisher / Cognition 101 (2006) 270–297an early stage, since the gene is so highly conserved in other (nonlinguistic) spe-
cies. Moreover, it is not obvious that cognitive scientists do become interested in
the molecular pathways once the relevant genes are identiﬁed; even now discus-
sions regarding the role of FOXP2 in human speech and language do not tend
to exploit the relevant emerging data from molecular studies, but remain focused
on approaches that were possible prior to isolation of the gene (Bosman, Garcia,
& Aboitiz, 2004; Corballis, 2004).
Putting all these issues aside, it remains to be seen whether or not we will ever
identify a gene which appears to have speciﬁc inﬂuences on particular aspects of cog-
nition, such as phoneme awareness, or grammatical processing, but I doubt that nat-
ure will present us with anything quite so tidy. Consideration of everything we have
learned thus far from genetic studies of neurodevelopmental disorders leads to one
inescapable conclusion. If we are able to place ﬁndings into a framework of systems
biology that acknowledges molecular and developmental complexity, we will greatly
improve our chances of untangling the webs that link genes to cognition.Acknowledgements
Simon Fisher is a Royal Society Research Fellow. His work is also supported by
project grants from the Wellcome Trust, and the Brain Sciences Initiative of the
U.K. Medical Research Council. Thanks to three anonymous reviewers for construc-
tive criticisms of an earlier draft of this article.References
Arcos-Burgos, M., Castellanos, F. X., Pineda, D., Lopera, F., Palacio, J. D., Palacio, L. G., et al. (2004).
Attention-deﬁcit/hyperactivity disorder in a population isolate: linkage to loci at 4q13.2, 5q33.3,
11q22, and 17p11. American Journal of Human Genetics, 75, 998–1014.
Bakker, S. C., van der Meulen, E. M., Buitelaar, J. K., Sandkuijl, L. A., Pauls, D. L., Monsuur, A. J.,
et al. (2003). A whole-genome scan in 164 Dutch sib pairs with attention-deﬁcit/hyperactivity disorder:
suggestive evidence for linkage on chromosomes 7p and 15q. American Journal of Human Genetics, 72,
1251–1260.
Bartlett, C. W., Flax, J. F., Logue, M. W., Vieland, V. J., Bassett, A. S., Tallal, P., et al. (2002). A major
susceptibility locus for speciﬁc language impairment is located on 13q21. American Journal of Human
Genetics, 71, 45–55.
Bell, J. I. (2003). The double helix in clinical practice. Nature, 421, 414–416.
Bosman, C., Garcia, R., & Aboitiz, F. (2004). FOXP2 and the language working-memory system. Trends
in Cognitive Sciences, 8, 251–252.
Botstein, D., & Risch, N. (2003). Discovering genotypes underlying human phenotypes: past successes for
mendelian disease, future approaches for complex disease. Nature Genetics, 33(Suppl), 228–237.
Boyd, R., & Silk, J. B. (2000). How humans evolved. New York: W.W. Norton.
Buxbaum, J. D., Silverman, J. M., Smith, C. J., Kilifarski, M., Reichert, J., Hollander, E., et al. (2001).
Evidence for a susceptibility gene for autism on chromosome 2 and for genetic heterogeneity. American
Journal of Human Genetics, 68, 1514–1520.
Carlsson, P., & Mahlapuu, M. (2002). Forkhead transcription factors: key players in development and
metabolism. Developmental Biology, 250, 1–23.
S.E. Fisher / Cognition 101 (2006) 270–297 293Cardon, L. R., & Bell, J. I. (2001). Association study designs for complex diseases. Nature Reviews
Genetics, 2, 91–99.
Cardon, L. R., Smith, S. D., Fulker, D. W., Kimberling, W. J., Pennington, B. F., & DeFries, J. C. (1994).
Quantitative trait locus for reading disability on chromosome 6. Science, 266, 276–279.
Castles, A., & Coltheart, M. (1993). Varieties of developmental dyslexia. Cognition, 47, 149–180.
Chomsky, N. (1980). Rules and representations. New York: Columbia University Press.
Collaborative Linkage Study of Autism (CLSA) (2001). An autosomal genomic screen for autism.
American Journal of Medical Genetics, 105, 609-615.
Collins, F. S., Green, E. D., Guttmacher, A. E., & Guyer, M. S. (2003). A vision for the future of genomics
research. Nature, 422, 835–847.
Cope, N., Harold, D., Hill, G., Moskvina, V., Stevenson, J., Holmans, P., et al. (2005a). Strong evidence
that KIAA0319 on chromosome 6p is a susceptibility gene for developmental dyslexia. American
Journal of Human Genetics, 76, 581–591.
Cope, N. A., Hill, G., vandenBree, M., Harold, D., Moskvina, V., Green, E. K., et al. (2005b). No
support for association between dyslexia susceptibility 1 candidate 1 and developmental dyslexia.
Molecular Psychiatry, 10, 237–238.
Corballis, M. C. (2004). FOXP2 and the mirror system. Trends in Cognitive Sciences, 8, 95–96.
Deﬀenbacher, K. E., Kenyon, J. B., Hoover, D. M., Olson, R. K., Pennington, B. F., DeFries, J. C., et al.
(2004). Reﬁnement of the 6p21.3 quantitative trait locus inﬂuencing dyslexia: linkage and association
analyses. Human Genetics, 115, 128–138.
de Kovel, C. G., Hol, F. A., Heister, J. G., Willemen, J. J., Sandkuijl, L. A., Franke, B., et al. (2004).
Genomewide scan identiﬁes susceptibility locus for dyslexia on Xq27 in an extended Dutch family.
Journal of Medical Genetics, 41, 652–657.
DiMaio, S., Grizenko, N., & Joober, R. (2003). Dopamine genes and attention-deﬁcit hyperactivity
disorder: a review. Journal of Psychiatry and Neuroscience, 28, 27–38.
Enard, W., Przeworski, M., Fisher, S. E., Lai, C. S. L., Wiebe, V., Kitano, T., et al. (2002). Molecular
evolution of FOXP2, a gene involved in speech and language. Nature, 418, 869–872.
Fagerheim, T., Raeymaekers, P., Tonnessen, F. E., Pedersen, M., Tranebjaerg, L., & Lubs, H. A. (1999). A
new gene (DYX3) for dyslexia is located on chromosome 2. Journal of Medical Genetics, 36, 664–669.
Ferland, R. J., Cherry, T. J., Preware, P. O., Morrisey, E. E., & Walsh, C. A. (2003). Characterization of
Foxp2 and Foxp1 mRNA and protein in the developing and mature brain. Journal of Comparative
Neurology, 460, 266–279.
Field, L. L., & Kaplan, B. J. (1998). Absence of linkage of phonological coding dyslexia to chromosome
6p23-p21.3 in a large family data set. American Journal of Human Genetics, 63, 1448–1456.
Fisher, S. E., & DeFries, J. C. (2002). Developmental dyslexia: genetic dissection of a complex cognitive
trait. Nature Reviews Neuroscience, 3, 767–780.
Fisher, S. E., Francks, C. (2006). Genes, cognition and dyslexia: learning to read the genome. Trends in
Cognitive Sciences, 10, in press.
Fisher, S. E., Francks, C., McCracken, J. T., McGough, J. J., Marlow, A. J., MacPhie, I. L., et al.
(2002a). A genomewide scan for loci involved in attention-deﬁcit/hyperactivity disorder. American
Journal of Human Genetics, 70, 1183–1196.
Fisher, S. E., Francks, C., Marlow, A. J., MacPhie, I. L., Newbury, D. F., Cardon, L. R., et al. (2002b).
Independent genome-wide scans identify a chromosome 18 quantitative-trait locus inﬂuencing
dyslexia. Nature Genetics, 30, 86–91.
Fisher, S. E., Lai, C. S. L., & Monaco, A. P. (2003). Deciphering the genetic basis of speech and language
disorders. Annual Review of Neuroscience, 26, 57–80.
Fisher, S. E., Marlow, A. J., Lamb, J., Maestrini, E., Williams, D. F., Richardson, A. J., et al. (1999). A
quantitative-trait locus on chromosome 6p inﬂuences diﬀerent aspects of developmental dyslexia.
American Journal of Human Genetics, 64, 146–156.
Fisher, S. E., & Marcus, G. F. (2006). The eloquent ape: genes, brains and the evolution of language.
Nature Reviews Genetics, 7, 9–20.
Fisher, S. E., Vargha-Khadem, F., Watkins, K. E., Monaco, A. P., & Pembrey, M. E. (1998). Localisation
of a gene implicated in a severe speech and language disorder. Nature Genetics, 18, 168–170.
294 S.E. Fisher / Cognition 101 (2006) 270–297Flint, J., & Knight, S. (2003). The use of telomere probes to investigate submicroscopic rearrangements
associated with mental retardation. Current Opinion in Genetics and Development, 13, 310–316.
Folstein, S. E., & Rosen-Sheidley, B. (2001). Genetics of autism: complex aetiology for a heterogeneous
disorder. Nature Reviews Genetics, 2, 943–955.
Francks, C., Fisher, S. E., Olson, R. K., Pennington, B. F., Smith, S. D., DeFries, J. C., et al. (2002). Fine
mapping of the chromosome 2p12-16 dyslexia susceptibility locus: quantitative association analysis
and positional candidate genes SEMA4F and OTX1. Psychiatric Genetics, 12, 35–41.
Francks, C., Paracchini, S., Smith, S. D., Richardson, A. J., Scerri, T. S., Cardon, L. R., et al.
(2004). A 77-kilobase region of chromosome 6p22.2 is associated with dyslexia in families from
the United Kingdom and from the United States. American Journal of Human Genetics, 75,
1046–1058.
Freimer, N., & Sabatti, C. (2003). The human phenome project. Nature Genetics, 34, 15–21.
Gauthier, J., Bonnel, A., St-Onge, J., Karemera, L., Laurent, S., Mottron, L., et al. (2004). NLGN3/
NLGN4 gene mutations are not responsible for autism in the Quebec population. American Journal of
Medical Genetics Part B, 132, 74–75.
Gaya´n, J., & Olson, R. K. (2001). Genetic and environmental inﬂuences on orthographic and
phonological skills in children with reading disabilities. Developmental Neuropsychology, 20,
483–507.
Gaya´n, J., Smith, S. D., Cherny, S. S., Cardon, L. R., Fulker, D. W., Brower, A. M., et al. (1999).
Quantitative-trait locus for speciﬁc language and reading deﬁcits on chromosome 6p. American Journal
of Human Genetics, 64, 157–164.
Glazier, A. M., Nadeau, J. H., & Aitman, T. J. (2002). Finding genes that underlie complex traits. Science,
298, 2345–2349.
Goldberg, T. E., & Weinberger, D. R. (2004). Genes and the parsing of cognitive processes. Trends in
Cognitive Sciences, 8, 325–335.
Gopnik, M. (1990). Feature-blind grammar and dysphasia. Nature, 344, 715, [correspondence].
Gopnik, M., & Crago, M. B. (1991). Familial aggregation of a developmental language disorder.
Cognition, 39, 1–50.
Grant, S. G. (2003). Systems biology in neuroscience: bridging genes to cognition. Current Opinion in
Neurobiology., 13, 577–582.
Grigorenko, E. L. (2001). Developmental dyslexia: an update on genes, brains, and environments. Journal
of Child Psychology and Psychiatry, 42, 91–125.
Grigorenko, E. L., Wood, F. B., Meyer, M. S., Hart, L. A., Speed, W. C., Shuster, A., et al. (1997).
Susceptibility loci for distinct components of developmental dyslexia on chromosomes 6 and 15.
American Journal of Human Genetics, 60, 27–39.
Grigorenko, E. L., Wood, F. B., Meyer, M. S., & Pauls, D. L. (2000). Chromosome 6p inﬂuences on
diﬀerent dyslexia-related cognitive processes: further conﬁrmation. American Journal of Human
Genetics, 66, 715–723.
Habib, M. (2000). The neurological basis of developmental dyslexia: an overview and working hypothesis.
Brain, 123, 2373–2399.
Hannula-Jouppi, K., Kaminen-Ahola, N., Taipale, M., Eklund, R., Nopola-Hemmi, J., Kaariainen, H.,
et al. (2005). The axon guidance receptor gene ROBO1 is a candidate gene for developmental dyslexia.
Public Library of Science Genetics, 1, e50.
Hauser, M. D., Chomsky, N., & Fitch, W. T. (2002). The faculty of language: What is it, who has it, and
how did it evolve?. Science 298, 1569–1579.
Hohnen, B., & Stevenson, J. (1999). The structure of genetic inﬂuences on general cognitive, language,
phonological, and reading abilities. Developmental Psychology, 35, 590–603.
Hood, L., & Galas, D. (2003). The digital code of DNA. Nature, 421, 444–448.
Inoue, K., & Lupski, J. R. (2003). Genetics and genomics of behavioral and psychiatric disorders. Current
Opinion in Genetics and Development, 13, 303–309.
International Molecular Genetic Study of Autism Consortium (IMGSAC). (1998). A full genome screen
for autism with evidence for linkage to a region on chromosome 7q. Human Molecular Genetics, 7,
571–578.
S.E. Fisher / Cognition 101 (2006) 270–297 295International Molecular Genetic Study of Autism Consortium (IMGSAC) (2001). A genomewide screen
for autism: strong evidence for linkage to chromosomes 2q, 7q, and 16p. American Journal of Human
Genetics, 69, 570–581.
Jamain, S., Quach, H., Betancur, C., Rastam, M., Colineaux, C., Gillberg, I. C. et al. Paris
Autism Research International Sibpair Study. (2003). Mutations of the X-linked genes
encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nature Genetics, 34,
27–29.
Kakiuchi, C., Iwamoto, K., Ishiwata, M., Bundo, M., Kasahara, T., Kusumi, I., et al. (2003). Impaired
feedback regulation of XBP1 as a genetic risk factor for bipolar disorder. Nature Genetics, 35, 171–175.
Kaminen, N., Hannula-Jouppi, K., Kestila, M., Lahermo, P., Muller, K., Kaaranen, M., et al. (2003). A
genome scan for developmental dyslexia conﬁrms linkage to chromosome 2p11 and suggests a new
locus on 7q32. Journal of Medical Genetics, 40, 340–345.
Kaplan, D. E., Gayaı´n, J., Ahn, J., Won, T. W., Pauls, D., Olson, R. K., et al. (2002). Evidence for
linkage and association with reading disability on 6p21.3-22. American Journal of Human Genetics, 70,
1287–1298.
Korstanje, R., & Paigen, B. (2002). From QTL to gene: the harvest begins. Nature Genetics, 31, 235–236.
Kuwabara, T., Hsieh, J., Nakashima, K., Taira, K., & Gage, F. H. (2004). A small modulatory dsRNA
speciﬁes the fate of adult neural stem cells. Cell, 116, 779–793.
Lai, C. S. L., Fisher, S. E., Hurst, J. A., Levy, E. R., Hodgson, S., Fox, M., et al. (2000). The SPCH1
region on human 7q31: genomic characterization of the critical interval and localization of
translocations associated with speech and language disorder. American Journal of Human Genetics,
67, 357–368.
Lai, C. S. L., Fisher, S. E., Hurst, J. A., Vargha-Khadem, F., & Monaco, A. P. (2001). A novel
forkhead-domain gene is mutated in a severe speech and language disorder. Nature, 413,
519–523.
Lai, C. S. L., Gerrelli, D., Monaco, A. P., Fisher, S. E., & Copp, A. J. (2003). FOXP2 expression during
brain development coincides with adult sites of pathology in a severe speech and language disorder.
Brain, 126, 2455–2462.
Lander, E., & Kruglyak, L. (1995). Genetic dissection of complex traits: guidelines for interpreting and
reporting linkage results. Nature Genetics, 11, 241–247.
Lander, E. S., & Schork, N. J. (1994). Genetic dissection of complex traits. Science, 265, 2037–2048.
Lehmann, O. J., Sowden, J. C., Carlsson, P., Jordan, T., & Bhattacharya, S. S. (2003). Fox’s in
development and disease. Trends in Genetics, 19, 339–344.
Lieberman, P. (2002). On the nature and evolution of the neural bases of human language. Yearbook of
Physical Anthropology, 45, 36–62.
Liegeois, F., Baldeweg, T., Connelly, A., Gadian, D. G., Mishkin, M., & Vargha-Khadem, F. (2003).
Language fMRI abnormalities associated with FOXP2 gene mutation. Nature Neuroscience, 6,
1230–1237.
MacDermot, K. D., Bonora, E., Sykes, N., Coupe, A. M., Lai, C. S. L., Vernes, S. C., et al. (2005).
Identiﬁcation of FOXP2 truncation as a novel cause of developmental speech and language deﬁcits.
American Journal of Human Genetics, 76, 1074–1080.
Marcus, G. F. (2003). The birth of the mind: How a tiny number of genes creates the complexities of human
thought. New York: Basic Books.
Marcus, G. F., & Fisher, S. E. (2003). FOXP2 in focus: what can genes tell us about speech and language?.
Trends in Cognitve Sciences 7, 257–262.
Marcus, G. F., Vouloumanos, A., & Sag, I. A. (2003). Does Broca’s play by the rules?. Nature
Neuroscience 6, 651–652.
Marino, C., Giorda, R., Luisa Lorusso, M., Vanzin, L., Salandi, N., Nobile, M., et al. (2005). A family-
based association study does not support DYX1C1 on 15q21.3 as a candidate gene in developmental
dyslexia. European Journal of Human Genetics, 13, 491–499.
Marlow, A. J., Fisher, S. E., Francks, C., MacPhie, I. L., Cherny, S. S., Richardson, A. J., et al. (2003).
Use of multivariate linkage analysis for dissection of a complex cognitive trait. American Journal of
Human Genetics, 72, 561–570.
296 S.E. Fisher / Cognition 101 (2006) 270–297Marlow, A. J., Fisher, S. E., Richardson, A. J., Francks, C., Talcott, J. B., Monaco, A. P., et al. (2001).
Investigation of quantitative measures related to reading disability in a large sample of sib-pairs from
the UK. Behavior Genetics, 31, 219–230.
Meng, H., Smith, S. D., Hager, K., Held, M., Liu, J., Olson, R. K., et al. (2005). DCDC2 is associated
with reading disability and modulates neuronal development in the brain. Proceedings of the National
Academy of Sciences United States of America, 102, 17053–17058.
Middleton, F. A., & Strick, P. L. (2000). Basal ganglia and cerebellar loops: motor and cognitive circuits.
Brain Research Reviews, 31, 236–250.
Morris, C. A., & Mervis, C. B. (2000). Williams syndrome and related disorders. Annual Review of
Genomics and Human Genetics, 1, 461–484.
Newbury, D. F., Bonora, E., Lamb, J. A., Fisher, S. E., Lai, C. S. L., et al., and the International
Molecular Genetic Study of Autism Consortium. (2002). FOXP2 is not a major susceptibility gene for
autism or Speciﬁc Language Impairment (SLI). American Journal of Human Genetics, 70, 1318–1327.
Nopola-Hemmi, J., Myllyluoma, B., Haltia, T., Taipale, M., Ollikainen, V., Ahonen, T., et al. (2001). A
dominant gene for developmental dyslexia on chromosome 3. Journal of Medical Genetics, 38, 658–664.
O’Brien, E. K., Zhang, X., Nishimura, C., Tomblin, J. B., & Murray, J. C. (2003). Association of Speciﬁc
Language Impairment (SLI) to the Region of 7q31. American Journal of Human Genetics, 72,
1536–1543.
Ogdie, M. N., Macphie, I. L., Minassian, S. L., Yang, M., Fisher, S. E., Francks, C., et al. (2003). A
genomewide scan for attention-deﬁcit/hyperactivity disorder in an extended sample: suggestive linkage
on 17p11. American Journal of Human Genetics, 72, 1268–1279.
Pa¨a¨bo, S. (2003). The mosaic that is our genome. Nature, 421, 409–412.
Page, G. P., George, V., Go, R. C., Page, P. Z., & Allison, D. B. (2003). Are we there yet?: Deciding when
one has demonstrated speciﬁc genetic causation in complex diseases and quantitative traits. American
Journal of Human Genetics, 73, 711–719.
Pennington, B. F. (1997). Using genetics to dissect cognition. American Journal of Human Genetics, 60,
13–16.
Philippe, A., Martinez, M., Guilloud-Bataille, M., Gillberg, C., Rastam, M., Sponheim, E., et al. (1999).
Genome-wide scan for autism susceptibility genes, Paris Autism Research International Sibpair Study.
Human Molecular Genetics, 8, 805–812.
Pinker, S. (1994). The language instinct. London: Allen Lane.
Reich, D. E., & Lander, E. S. (2001). On the allelic spectrum of human disease. Trends in Genetics, 17,
502–510.
Roizen, N. J., & Patterson, D. (2003). Down’s syndrome. Lancet, 361, 1281–1289.
Saleem, R. A., Banerjee-Basu, S., Berry, F. B., Baxevanis, A. D., & Walter, M. A. (2003). Structural and
functional analyses of disease-causing missense mutations in the forkhead domain of FOXC1. Human
Molecular Genetics, 12, 2993–3005.
Scerri, T. S., Fisher, S. E., Francks, C., MacPhie, I. L., Paracchini, S., Richardson, A. J., et al. (2004).
Putative functional alleles of DYX1C1 are not associated with dyslexia susceptibility in a large sample
of sibling pairs from the UK. Journal of Medical Genetics, 41, 853–857.
Schulte-Ko¨rne, G., Grimm, T., Nothen, M. M., Muller-Myhsok, B., Cichon, S., Vogt, I. R., et al. (1998).
Evidence for linkage of spelling disability to chromosome 15. American Journal of Human Genetics, 63,
279–282.
Shao, Y., Raiford, K. L., Wolpert, C. M., Cope, H. A., Ravan, S. A., Ashley-Koch, A. A., et al. (2002).
Phenotypic homogeneity provides increased support for linkage on chromosome 2 in autistic disorder.
American Journal of Human Genetics, 70, 1058–1061.
Shu, W., Yang, H., Zhang, L., Lu, M. M., & Morrisey, E. E. (2001). Characterization of a new subfamily
of winged-helix/forkhead (Fox) genes that are expressed in the lung and act as transcriptional
repressors. Journal of Biological Chemistry, 276, 27488–27497.
SLI Consortium (2002). A genomewide scan identiﬁes two novel loci involved in speciﬁc language
impairment. American Journal of Human Genetics, 70, 384–398.
SLI Consortium (2004). Highly signiﬁcant linkage to the SLI1 locus in an expanded sample of individuals
aﬀected by speciﬁc language impairment. American Journal of Human Genetics, 74, 1225–1238.
S.E. Fisher / Cognition 101 (2006) 270–297 297Smith, S. D., Kimberling, W. J., Pennington, B. F., & Lubs, H. A. (1983). Speciﬁc reading disability:
identiﬁcation of an inherited form through linkage analysis. Science, 219, 1345.
Snowling, M. J. (2001). From language to reading and dyslexia. Dyslexia, 7, 37–46.
Takahashi, K., Liu, F. C., Hirokawa, K., & Takahashi, H. (2003). Expression of Foxp2, a gene involved in
speech and language, in the developing and adult striatum. Journal of Neuroscience Research, 73,
61–72.
Taipale, M., Kaminen, N., Nopola-Hemmi, J., Haltia, T., Myllyluoma, B., Lyytinen, H., et al. (2003). A
candidate gene for developmental dyslexia encodes a nuclear tetratricopeptide repeat domain protein
dynamically regulated in brain. Proceedings of the National Academy of Sciences United States of
America, 100, 11553–11558.
Turic, D., Robinson, L., Duke, M., Morris, D. W., Webb, V., Hamshere, M., et al. (2003). Linkage
disequilibrium mapping provides further evidence of a gene for reading disability on chromosome
6p21.3-22. Molecular Psychiatry, 8, 176–185.
Tzenova, J., Kaplan, B. J., Petryshen, T. L., & Field, L. L. (2004). Conﬁrmation of a dyslexia susceptibility
locus on chromosome 1p34-p36 in a set of 100 Canadian families. American Journal of Medical
Genetics Part B, 127, 117–124.
Ullman, M. T., & Gopnik, M. (1999). Inﬂectional morphology in a family with inherited speciﬁc language
impairment. Applied Psycholinguistics, 20, 51–117.
Vargha-Khadem, F., Gadian, D. G., Copp, A., & Mishkin, M. (2005). FOXP2 and the neuroanatomy of
speech and language. Nature Reviews Neuroscience, 6, 131–138.
Vargha-Khadem, F., Watkins, K., Alcock, K., Fletcher, P., & Passingham, R. (1995). Praxic and
nonverbal cognitive deﬁcits in a large family with a genetically transmitted speech and language
disorder. Proceedings of the National Academy of Sciences United States of America, 92, 930–933.
Vargha-Khadem, F., Watkins, K. E., Price, C. J., Ashburner, J., Alcock, K. J., Connelly, A., et al. (1998).
Neural basis of an inherited speech and language disorder. Proceedings of the National Academy of
Sciences United States of America, 95, 12695–12700.
Vincent, J. B., Kolozsvari, D., Roberts, W. S., Bolton, P. F., Gurling, H. M. D, & Scherer, S. W. (2004).
Mutation screening of X-chromosomal neuroligin genes: No mutations in 196 autism probands.
American Journal of Medical Genetics Part B, 129, 82–84.
Wassink, T. H., Brzustowicz, L. M., Bartlett, C. W., & Szatmari, P. (2004). The search for autism disease
genes. Mental Retardation in Developmental Disabilities Research Reviews, 10, 272–283.
Watkins, K. E., Dronkers, N. F., & Vargha-Khadem, F. (2002). Behavioural analysis of an inherited
speech and language disorder: comparison with acquired aphasia. Brain, 125, 452–464.
Welsh, J. P., Lang, E. J., Suglhara, I., & Llinas, R. (1995). Dynamic organization of motor control within
the olivocerebellar system. Nature, 374, 453–457.
Wigg, K. G., Couto, J. M., Feng, Y., Anderson, B., Cate-Carter, T. D., Macciardi, F., et al. (2004).
Support for EKN1 as the susceptibility locus for dyslexia on 15q21. Molecular Psychiatry, 9,
1111–1121.
Wolf, M., & Bowers, P. G. (2000). Naming-speed processes and developmental reading disabilities: An
introduction to the special issue on the double-deﬁcit hypothesis. Journal of Learning Disabilities, 33,
322–324.
Wolfsberg, T. G., McEntyre, J., & Schuler, G. D. (2001). Guide to the draft human genome. Nature, 409,
824–826.
Yonan, A. L., Alarcon, M., Cheng, R., Magnusson, P. K., Spence, S. J., Palmer, A. A., et al. (2003). A
genomewide screen of 345 families for autism-susceptibility loci. American Journal of Human Genetics,
73, 886–897.
Zhang, J., Webb, D. M., & Podlaha, O. (2002). Accelerated Protein Evolution and Origins of Human-
Speciﬁc Features. Foxp2 as an example. Genetics, 162, 1825–1835.
